Attitudes toward metabolic adverse events among patients with schizophrenia in Japan

por Sugawara N, Yasui-Furukori N, Yamazaki M, Shimoda K, Mori T, Sugai T, Matsuda H, Suzuki Y, Minami Y, Ozeki Y, Okamoto K, Sagae T, Someya T
Publicado 2016

Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment

por Kawamata Y, Sugawara N, Ishioka M, Kubo K, Suzuki K, Fujii A, Furukori H, Nakagami T, Yasui-Furukori N, Shimoda K
Publicado 2021

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder

por Aoki A, Ishiguro S, Watanabe T, Ueda M, Hayashi Y, Akiyama K, Kato K, Inoue Y, Tsuchimine S, Yasui-Furukori N, Shimoda K
Publicado 2014